| Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients MS Jawahar, VV Banurekha, CN Paramasivan, F Rahman, ... PLoS One 8 (7), e67030, 2013 | 127 | 2013 |
| Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial S Swaminathan, G Narendran, P Venkatesan, S Iliayas, ... American journal of respiratory and critical care medicine 181 (7), 743-751, 2010 | 125 | 2010 |
| Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis F Fregonese, SD Ahuja, OW Akkerman, D Arakaki-Sanchez, I Ayakaka, ... The lancet respiratory medicine 6 (4), 265-275, 2018 | 114 | 2018 |
| Efficacy and safety of once-daily nevirapine-or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial S Swaminathan, C Padmapriyadarsini, P Venkatesan, G Narendran, ... Clinical Infectious Diseases 53 (7), 716-724, 2011 | 91 | 2011 |
| Bedaquiline, delamanid, linezolid, and clofazimine for treatment of pre-extensively drug-resistant tuberculosis C Padmapriyadarsini, V Vohra, A Bhatnagar, R Solanki, R Sridhar, ... Clinical Infectious Diseases 76 (3), e938-e946, 2023 | 87 | 2023 |
| Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A … B Velayutham, VK Chadha, N Singla, P Narang, V Gangadhar Rao, ... PLoS One 13 (7), e0200150, 2018 | 57 | 2018 |
| Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial S Swaminathan, PA Menon, N Gopalan, V Perumal, ... PloS one 7 (12), e47400, 2012 | 57 | 2012 |
| Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy S Soumya, CN Deivanayagam, S Rajasekaran, P Venkatesan, PA Menon, ... National Medical Journal of India 21 (1), 3-8, 2008 | 53 | 2008 |
| Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study A Gupte, C Padmapriyadarsini, V Mave, D Kadam, N Suryavanshi, ... BMJ open 6 (2), e010542, 2016 | 50 | 2016 |
| Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care—An experience from South India N Gopalan, S Senthil, NL Prabakar, T Senguttuvan, A Bhaskar, ... PLoS One 17 (2), e0263471, 2022 | 49 | 2022 |
| Impact of undernutrition on tuberculosis treatment outcomes in India: a multicenter, prospective, cohort analysis P Sinha, C Ponnuraja, N Gupte, S Prakash Babu, SR Cox, S Sarkar, ... Clinical Infectious Diseases 76 (8), 1483-1491, 2023 | 44 | 2023 |
| Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol … C Padmapriyadarsini, PK Bhavani, M Natrajan, C Ponnuraja, H Kumar, ... BMJ open 9 (3), e024363, 2019 | 44 | 2019 |
| Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India S Swaminathan, CN Paramasivan, C Ponnuraja, S Iliayas, S Rajasekaran, ... The International Journal of Tuberculosis and Lung Disease 9 (8), 896-900, 2005 | 42 | 2005 |
| Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysis VS Salhotra, KS Sachdeva, N Kshirsagar, M Parmar, R Ramachandran, ... indian journal of tuberculosis 67 (1), 29-37, 2020 | 39 | 2020 |
| An integrative machine learning framework for classifying SEER breast cancer P Manikandan, U Durga, C Ponnuraja Scientific Reports 13 (1), 5362, 2023 | 35 | 2023 |
| The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis MT Pho, S Swaminathan, N Kumarasamy, E Losina, C Ponnuraja, ... PloS one 7 (4), e36001, 2012 | 35 | 2012 |
| Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India BV Velayutham, IS Allaudeen, GN Sivaramakrishnan, V Perumal, D Nair, ... Clinical Infectious Diseases 59 (10), e142-e149, 2014 | 25 | 2014 |
| Distribution and growth rate of COVID-19 outbreak in Tamil Nadu: A log-linear regression approach A Bhaskar, C Ponnuraja, R Srinivasan, S Padmanaban Indian Journal of Public Health 64 (6), 188-191, 2020 | 24 | 2020 |
| Miliary tuberculosis in human immunodeficiency virus infected patients not on antiretroviral therapy: clinical profile and response to shortcourse chemotherapy S Swaminathan, C Padmapriyadarsini, C Ponnuraja, CH Sumathi, ... Journal of Postgraduate Medicine 53 (4), 228-231, 2007 | 24 | 2007 |
| Evaluation of directly observed treatment providers in the revised National Tuberculosis Control Programme C Nirupa, G Sudha, T Santha, C Ponnuraja, R Fathima, ... Indian Journal of Tuberculosis 52 (2), 73-77, 2005 | 24 | 2005 |
